Matthew Shawn Morris Sells 88,110 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director Matthew Shawn Morris sold 88,110 shares of Privia Health Group stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $25.33, for a total transaction of $2,231,826.30. Following the sale, the director owned 76,651 shares in the company, valued at $1,941,569.83. This represents a 53.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shawn Morris also recently made the following trade(s):

• On Monday, June 29th, Matthew Shawn Morris sold 63,212 shares of Privia Health Group stock. The shares were sold at an average price of $25.33, for a total transaction of $1,601,159.96.
• On Friday, May 1st, Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock. The shares were sold at an average price of $24.99, for a total transaction of $427,229.04.
• On Monday, May 4th, Matthew Shawn Morris sold 1,017 shares of Privia Health Group stock. The shares were sold at an average price of $24.96, for a total transaction of $25,384.32.

Privia Health Group Price Performance

Privia Health Group stock opened at $26.88 on Thursday. Privia Health Group, Inc. has a 12-month low of $18.77 and a 12-month high of $27.11. The company has a market capitalization of $3.39 billion, a price-to-earnings ratio of 168.01, a price-to-earnings-growth ratio of 2.04 and a beta of 0.83. The firm’s fifty day moving average price is $23.31 and its 200 day moving average price is $22.98.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.11. The company had revenue of $603.85 million during the quarter, compared to analysts’ expectations of $560.99 million. Privia Health Group had a net margin of 0.97% and a return on equity of 2.81%. The firm’s revenue for the quarter was up 25.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.22 EPS. Analysts forecast that Privia Health Group, Inc. will post 0.27 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have weighed in on PRVA. Canaccord Genuity Group lowered their price objective on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Barclays reduced their target price on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Evercore set a $26.00 price target on shares of Privia Health Group in a research report on Wednesday, April 8th. Finally, Weiss Ratings lowered shares of Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Privia Health Group has an average rating of “Moderate Buy” and an average target price of $31.15.

Institutional Trading of Privia Health Group

Hedge funds and other institutional investors have recently bought and sold shares of the company. PNC Financial Services Group Inc. lifted its holdings in Privia Health Group by 9.6% during the 3rd quarter. PNC Financial Services Group Inc. now owns 7,731 shares of the company’s stock worth $193,000 after buying an additional 675 shares during the last quarter. State of Alaska Department of Revenue raised its position in shares of Privia Health Group by 1.3% during the 4th quarter. State of Alaska Department of Revenue now owns 65,747 shares of the company’s stock valued at $1,558,000 after acquiring an additional 823 shares in the last quarter. ProShare Advisors LLC raised its position in shares of Privia Health Group by 4.1% during the 4th quarter. ProShare Advisors LLC now owns 22,576 shares of the company’s stock valued at $535,000 after acquiring an additional 898 shares in the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in Privia Health Group by 5.9% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 16,250 shares of the company’s stock worth $385,000 after purchasing an additional 903 shares during the last quarter. Finally, Hantz Financial Services Inc. lifted its stake in Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after purchasing an additional 926 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.